Pélouard F, Chedru-Legros V, Nganoa C, Dompmartin A, L'Orphelin J-M. Optimizing targeted therapy for metastatic melanoma: a combination of encorafenib and trametinib beyond standard protocols. Dermatol Reports [Internet]. 2025 Apr. 15 [cited 2026 May 4];17(4). Available from: https://journals.pagepress.net/dr/article/view/10036